文献速递中药与中成药合理使用中医内科

中药与抗生素联用对抗多重耐药菌的潜力:进展、机制与临床意义

Potential of traditional Chinese medicine-antibiotic combinations in combating multidrug-resistant organisms: Advances, mechanisms, and clinical implications.
PubMed 文献 · J Ethnopharmacol · 2026-01-23

该综述基于PubMed和中国知网2002至2025年文献,总结中药(活性成分、药材及复方)联合抗生素对抗多重耐药菌的体外与临床证据。结果显示联用具有显著协同抗菌效应,可改善临床结局并减少耐药,但需加强作用机制与剂量疗效关系研究。

要点

  • 中药联合抗生素对多重耐药菌有协同抗菌作用,可改善临床结局。
  • 联用主要优势包括克服细菌耐药、缩短疗程和减少不良反应。
  • 未来需重点研究作用机制与剂量疗效关系,并开展严谨临床试验。

核心结论

  • 中药与抗生素联用对多重耐药菌感染有 promising 临床应用价值,通过多靶点作用与快速杀菌协同增强疗效并减缓耐药。

研究设计与样本

  • 综述检索PubMed和中国知网,关键词包括herb、TCM、Chinese herbal medicine、antibiotics、mechanism、clinical studies、in vitro experiments等,收集2002至2025年相关文献。

主要发现

  • 中药联合抗生素表现出显著协同抗菌效应,明显改善临床结局并有效降低抗生素耐药。
  • 主要治疗效应包括克服细菌耐药、缩短治疗时间和降低不良反应发生率。

临床怎么用

  • 可考虑在多重耐药菌感染中联合使用中药与抗生素以增强疗效并减少耐药,但需关注剂量与疗效关系。

局限性

  • 未来研究应更关注作用机制及剂量与疗效关系,以提高应用的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Multidrug-resistant organisms (MDROs) pose a severe global health threat, significantly complicating the treatment of bacterial infections. Traditional Chinese medicine (TCM), with its long history and rich clinical experience in treating infectious diseases, offers a unique and promising approach to enhance anti-infective efficacy and overcome resistance mechanisms when combined with antibiotics. The combination represents a novel strategy to combat MDROs. AIM OF THE STUDY: This review summarizes the efficacy of TCM (including active ingredients, herbs and prescriptions) combined with antibiotics against MDROs based on in vitro and clinical evidence, and outlines their advantages, challenges and future directions. MATERIALS AND METHODS: The review consulted the electronic databases PubMed and Chinese National Knowledge Infrastructure. keywords used for the search included "herb," "TCM," "Chinese herbal medicine," "antibiotics," "mechanism," "clinical studies," "in vitro experiments," and their combinations. Relevant literature was collected from 2002 to 2025. RESULTS: This review demonstrates that TCM-antibiotic combinations exhibit significant synergistic antibacterial effects, markedly enhancing clinical outcomes and effectively reducing antibiotic resistance. The primary therapeutic effects include overcoming bacterial resistance, reduced treatment duration, and lower incidence of adverse effects. However, the future research should also pay more attention to the action mechanisms and the relationship between dosage and efficacy for the reliability of the applications. CONCLUSION: TCM-antibiotic combinations have promising clinical application value for addressing MDROs infections. By integrating the multi-target actions of TCM with the rapid bactericidal effects of antibiotics, this approach offers a synergistic solution that enhances clinical outcomes and mitigates the emergence of resistance. Future research should focus on translating these findings into clinical practice through rigorous mechanistic studies and well-designed clinical trials, ultimately aiming to develop optimized therapeutic protocols for the effective management of MDROs infections.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Qin X, Wu Y, Pang X, et al. Potential of traditional Chinese medicine-antibiotic combinations in combating multidrug-resistant organisms: Advances, mechanisms, and clinical implications. J Ethnopharmacol. 2026. PMID: 41581795. doi:10.1016/j.jep.2026.121261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。